open access

Vol 72, No 2 (2021)
Clinical vignette
Published online: 2021-01-19
Submitted: 2020-12-21
Accepted: 2021-01-08
Get Citation

Severe hypophosphataemic osteomalacia related to low-dose adefovir dipivoxil therapy in a hepatitis B virus patient

Xiushuai Dong, Xi Chen, Yaoyao Tian, Jinghua Wang
DOI: 10.5603/EP.a2021.0007
·
Pubmed: 33619716
·
Endokrynologia Polska 2021;72(2):181-182.

open access

Vol 72, No 2 (2021)
Clinical Vignette
Published online: 2021-01-19
Submitted: 2020-12-21
Accepted: 2021-01-08

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

hypophosphataemic osteomalacia; adefovir dipivoxil; chronic hepatitis B

About this article
Title

Severe hypophosphataemic osteomalacia related to low-dose adefovir dipivoxil therapy in a hepatitis B virus patient

Journal

Endokrynologia Polska

Issue

Vol 72, No 2 (2021)

Article type

Clinical vignette

Pages

181-182

Published online

2021-01-19

DOI

10.5603/EP.a2021.0007

Pubmed

33619716

Bibliographic record

Endokrynologia Polska 2021;72(2):181-182.

Keywords

hypophosphataemic osteomalacia
adefovir dipivoxil
chronic hepatitis B

Authors

Xiushuai Dong
Xi Chen
Yaoyao Tian
Jinghua Wang

References (4)
  1. Leowattana W. Antiviral Drugs and Acute Kidney Injury (AKI). Infect Disord Drug Targets. 2019; 19(4): 375–382.
  2. Izzedine H, Hulot JS, Launay-Vacher V, et al. Adefovir Dipivoxil International 437 Study Group, Adefovir Dipivoxil International 438 Study Group. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int. 2004; 66(3): 1153–1158.
  3. Park S, Kim WI, Cho DH, et al. Adefovir-induced Fanconi syndrome associated with osteomalacia. Clin Mol Hepatol. 2017; 24(3): 339–344.
  4. Lv Y, Li X, Liang S, et al. The clinical and pathological features of adefovir dipivoxil-related renal impairment
. Clin Nephrol. 2019; 91(3): 180–186.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl